XTL Biopharmaceuticals Ltd. - Earnings Release 2021

Financial Results for a Period of Six Months Ending June 30, 2021 false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	24/08/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-137394	Time of broadcast: 20:58 20:58

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onFinancial Results for a Period of Six Months Ending June 30, 2021

ea146254-6k_xtlbiopharmaEDGAR5_Bannerless_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 10/08/2021
Address: HaCharoshet st 5 , Ra'anana 43656 Israel , Tel: 09-9557080 , Fax: 09-9519708
E-mail address: [email protected] Company site: www.xtlbio.com

Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD

Name of the Signatory: Kntor Ronen Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: abba hillel 12 , ramat gan 5250606 Telephone: 03-6133371 Facsimile: 03-6133372 E-mail: [email protected] 1

AI assistant